Overall Status

Completed (2)

Active, not recruiting (1)

Phase

phase 3 (2)

early phase 1 (1)

Sponsor

National Cancer Institute (NCI) (2)

Mayo Clinic (1)

Collaborator

NSABP Foundation Inc (1)

National Cancer Institute (NCI) (1)

Intervention

bevacizumab (2)

fluorouracil (2)

laboratory biomarker analysis (2)

leucovorin calcium (2)

oxaliplatin (2)

american ginseng (1)

placebo (1)

questionnaire administration (1)

Study Documents

Intervention Type

drug (3)

biological (2)

other (2)

Funder Type

NIH (2)

Other (1)

Study Type

Interventional (3)

stage iib colon cancer ajcc v7

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Colon Mucinous Adenocarcinoma, Colon Signet Ring Cell Adenocarcinoma, Lynch Syndrome Trial in Worldwide (biological, drug,

Active, not recruiting

Colon Mucinous Adenocarcinoma
+5 more

Bevacizumab
+4 more

Anniston, Alabama
+935 more

Oct 18, 2022

Cancer Survivor, Stage I Breast Cancer AJCC v7, Stage I Colon Cancer AJCC v6 and v7 Trial in Scottsdale (American Ginseng,

Completed

Cancer Survivor
+19 more

American Ginseng
+3 more

Scottsdale, Arizona

Mayo Clinic in Arizona

Mar 22, 2022

Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v7, Stage IIB Colon Cancer AJCC v7 Trial in Pittsburgh (Bevacizumab,

Completed

Has Results

Colon Adenocarcinoma
+6 more

Bevacizumab
+3 more

Pittsburgh, Pennsylvania

National Surgical Adjuvant Breast and Bowel Project

Jul 17, 2019